COMP <GO>
MIR vs TMO // FORWARD P/E MULTIPLE
Mirion Technologies Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MIR 4
— TMO 9
▲ FORWARD P/E MULTIPLE LEADER: TMO
LAST: $18.67 (+11.46%) • MKT CAP: $4.58B
forward-pe
140.0x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MIR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MIR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 47.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.10% | 9.30% | -7.20 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 56.0x | 30.4x | +25.60 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.33% | 2.40% | -0.07 | TMO | /fcf-yield <GO> |
| Operating Margin | 5.60% | 17.40% | -11.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 3.10% | 15.10% | -12.00 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 7.50% | 3.90% | +3.60 | MIR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.94 | 4.50 | -2.56 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | MIR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.0 | 62.9 | +7.10 | MIR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.94 | +0.04 | MIR | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 140.0x | 36.3x | +103.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.58B | $262.22B | -$257.63B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MIR REV | TMO REV | MIR GROSS % | TMO GROSS % | MIR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $925.4M | $44.56B | 47.4% | — | $106.9M | $6.29B |
| FY 2024 | $860.8M | $42.88B | 46.4% | — | $50.3M | $7.27B |
| FY 2023 | $800.9M | $42.86B | — | — | $59.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MIR // BETA 0.98
TMO // BETA 0.94